- Home
- PNW vs RVMD Comparison
PNW vs RVMD Comparison
Compare PNW & RVMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PNW
- RVMD
- Stock Information
- Founded
- PNW 1985
- RVMD 2014
- Country
- PNW United States
- RVMD United States
- Employees
- PNW N/A
- RVMD N/A
- Industry
- PNW Electric Utilities: Central
- RVMD Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- PNW Utilities
- RVMD Health Care
- Exchange
- PNW Nasdaq
- RVMD Nasdaq
- Market Cap
- PNW 10.3B
- RVMD 8.7B
- IPO Year
- PNW N/A
- RVMD 2020
- Fundamental
- Price
- PNW $87.54
- RVMD $45.01
- Analyst Decision
- PNW Buy
- RVMD Strong Buy
- Analyst Count
- PNW 13
- RVMD 13
- Target Price
- PNW $84.50
- RVMD $62.77
- AVG Volume (30 Days)
- PNW 1.2M
- RVMD 2.0M
- Earning Date
- PNW 11-06-2024
- RVMD 11-06-2024
- Dividend Yield
- PNW 4.08%
- RVMD N/A
- EPS Growth
- PNW 27.39
- RVMD N/A
- EPS
- PNW 5.34
- RVMD N/A
- Revenue
- PNW $5,021,081,000.00
- RVMD $742,000.00
- Revenue This Year
- PNW $5.58
- RVMD N/A
- Revenue Next Year
- PNW $3.11
- RVMD $299.87
- P/E Ratio
- PNW $16.43
- RVMD N/A
- Revenue Growth
- PNW 6.52
- RVMD N/A
- 52 Week Low
- PNW $65.20
- RVMD $25.58
- 52 Week High
- PNW $95.42
- RVMD $62.40
- Technical
- Relative Strength Index (RSI)
- PNW 35.63
- RVMD 29.39
- Support Level
- PNW $90.70
- RVMD $46.55
- Resistance Level
- PNW $93.23
- RVMD $48.91
- Average True Range (ATR)
- PNW 1.65
- RVMD 2.17
- MACD
- PNW -0.70
- RVMD -1.15
- Stochastic Oscillator
- PNW 0.63
- RVMD 3.35
About PNW Pinnacle West Capital Corporation
Pinnacle West is a holding company whose principal subsidiary is Arizona Public Service, a vertically integrated electric utility that serves 1.4 million customers across a 35,000-square-mile territory in central Arizona, including Phoenix. APS owns or leases more than 6 gigawatts of power generation capacity, including a 29% ownership stake in the largest nuclear plant in the US, Palo Verde. Half of the electricity that APS supplies to customers comes from clean energy sources, including nuclear.
About RVMD Revolution Medicines Inc.
Revolution Medicines Inc is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit elusive, frontier targets within notorious growth and survival pathways, with particular emphasis on the RAS and mTOR signaling pathways. The company's products includes RMC-4630, a SHP2 inhibitor, RAS(ON) portfolio, and SOS1 and 4EBP1/mTORC1 programs.